Comments to FDA and USP: Proposal of Limit for the Process Degradant 4-Aminophenol Share page: Download Document Issues: OTC Medicines Acetaminophen Other Issues Quality Related Posts Press Releases and Statements CHPA Applauds White House Executive Order Prioritizing Lower Drug Costs and Access to Self-Care Apr 17, 2025 Press Releases and Statements CHPA Responds to Section 232 Investigation on Pharmaceuticals Apr 15, 2025 Press Releases and Statements CHPA Commends Lawmakers for Urging FDA to Protect the Rx-OTC-Switch Pathway Apr 11, 2025
